LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Weak or discrepant RhD phenotypes: Laboratory management strategies for local patient populations.

    Barriteau, Christina M / Lindholm, Paul F / Hartman, Karyn / Pugh, Johnathon / Sumugod, Ricardo D / Ramsey, Glenn

    Transfusion

    2024  Volume 64, Issue 4, Page(s) 765–767

    MeSH term(s) Humans ; Phenotype ; Genotype ; Rh-Hr Blood-Group System/genetics ; Alleles
    Chemical Substances Rh-Hr Blood-Group System
    Language English
    Publishing date 2024-04-01
    Publishing country United States
    Document type Letter
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.17796
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: RHD genotyping to resolve weak and discrepant RhD patient phenotypes.

    Barriteau, Christina M / Lindholm, Paul F / Hartman, Karyn / Sumugod, Ricardo D / Ramsey, Glenn

    Transfusion

    2022  Volume 62, Issue 11, Page(s) 2194–2199

    Abstract: Background: We instituted RHD genotyping in our transfusion service for obstetrical patients and transfusion candidates. We sought to examine how RHD genotyping resolved weak or discrepant automated microplate direct agglutination (MDA) RhD phenotypings ...

    Abstract Background: We instituted RHD genotyping in our transfusion service for obstetrical patients and transfusion candidates. We sought to examine how RHD genotyping resolved weak or discrepant automated microplate direct agglutination (MDA) RhD phenotypings and impacted needs for Rh Immune Globulin (RhIG) and D-negative RBCs.
    Study design and methods: We investigated RhD phenotypes with equivocal or reagent-discrepant automated MDA (Immucor, Norcross, GA), weak-2+ immediate-spin tube typings, historically discrepant RhD typings, or D+ typings with anti-D. We performed microarray RHD genotyping (RHD BeadChip, Immucor BioArray Solutions, Warren, NJ). Patients were managed as D+ with weak-D types 1, 2, and 3, and as D-negative with all other results.
    Results: Our weak-D prevalence was 0.14%. Among 138 patients (73 obstetrics, 65 transfusion candidates), 38% had weak-D types 1, 2 or 3, 25% weak partial type 4.0, 21% other partial-D variant alleles, and 15% no variant detected. One novel allele with weak partial type 4.0 variants plus c.150T>C (Val50Val) was discovered. Weak D types 1, 2 or 3 were identified in 66% (48/73) of Whites versus 3% (2/62) of diverse ethnic patients (p < .0001). RHD genotyping changed RhD management in 60 patients (43%) (49 to D+, 11 to D-negative), resulting in net conservation of D-negative RBCs (98 avoided, 14 given) and RhIG (8 avoided, 3 given).
    Conclusion: In our patient population, equivocal or reagent-discrepant MDA RhD phenotypes were highly specific for weak-D or partial-D RHD genotypes. Resolution of RHD genotype status reduced our use of D-negative RBCs and RhIG.
    MeSH term(s) Pregnancy ; Female ; Humans ; Rh-Hr Blood-Group System/genetics ; Genotype ; Phenotype ; Alleles ; Blood Transfusion
    Chemical Substances Rh-Hr Blood-Group System
    Language English
    Publishing date 2022-10-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.17145
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Blood transfusion utilization in hospitalized COVID-19 patients.

    Barriteau, Christina M / Bochey, Patricia / Lindholm, Paul F / Hartman, Karyn / Sumugod, Ricardo / Ramsey, Glenn

    Transfusion

    2020  Volume 60, Issue 9, Page(s) 1919–1923

    Abstract: Background: The acute respiratory illness designated coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019 and caused a worldwide pandemic. Concerns arose about the impact of the COVID-19 pandemic on blood donations ... ...

    Abstract Background: The acute respiratory illness designated coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019 and caused a worldwide pandemic. Concerns arose about the impact of the COVID-19 pandemic on blood donations and potential significant blood transfusion needs in severely ill COVID-19 patients. Data on blood usage in hospitalized COVID-19 patients are scarce.
    Study design and methods: We performed a retrospective observational study of blood component transfusions in the first 4 weeks of COVID-19 ward admissions. The study period began 14 days before the first COVID-19 cohort wards opened in our hospital in March 2020 and ended 28 days afterward. The number of patients and blood components transfused in the COVID-19 wards was tabulated. Transfusion rates of each blood component were compared in COVID-19 wards versus all other inpatient wards.
    Results: COVID-19 wards opened with seven suspected patients and after 4 weeks had 305 cumulative COVID-19 admissions. Forty-one of 305 hospitalized COVID-19 patients (13.4%) received transfusions with 11.1% receiving red blood cells (RBCs), 1.6% platelets (PLTs), 1.0% plasma, and 1.0% cryoprecipitate (cryo). COVID-19 wards had significantly lower transfusion rates compared to non-COVID wards for RBCs (0.03 vs 0.08 units/patient-day), PLTs (0.003 vs 0.033), and plasma (0.002 vs 0.018; all p < 0.0001). Cryo rates were similar (0.008 vs 0.009, p = 0.6).
    Conclusions: Hospitalized COVID-19 patients required many fewer blood transfusions than other hospitalized patients. COVID-19 transfusion data will inform planning and preparation of blood resource utilization during the pandemic.
    MeSH term(s) Academic Medical Centers/statistics & numerical data ; Appointments and Schedules ; Blood Component Transfusion/statistics & numerical data ; Blood Transfusion/statistics & numerical data ; COVID-19/complications ; COVID-19/therapy ; Chicago ; Disseminated Intravascular Coagulation/etiology ; Disseminated Intravascular Coagulation/therapy ; Elective Surgical Procedures ; Health Services Needs and Demand/statistics & numerical data ; Hospital Departments ; Hospitals, Urban/statistics & numerical data ; Humans ; Inpatients/statistics & numerical data ; Procedures and Techniques Utilization ; Retrospective Studies
    Keywords covid19
    Language English
    Publishing date 2020-07-04
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.15947
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Blood transfusion utilization in hospitalized COVID-19 patients

    Barriteau, Christina M / Bochey, Patricia / Lindholm, Paul F / Hartman, Karyn / Sumugod, Ricardo / Ramsey, Glenn

    Transfusion

    Abstract: BACKGROUND: The acute respiratory illness designated coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019 and caused a worldwide pandemic. Concerns arose about the impact of the COVID-19 pandemic on blood donations and ...

    Abstract BACKGROUND: The acute respiratory illness designated coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019 and caused a worldwide pandemic. Concerns arose about the impact of the COVID-19 pandemic on blood donations and potential significant blood transfusion needs in severely ill COVID-19 patients. Data on blood usage in hospitalized COVID-19 patients are scarce. STUDY DESIGN AND METHODS: We performed a retrospective observational study of blood component transfusions in the first 4 weeks of COVID-19 ward admissions. The study period began 14 days before the first COVID-19 cohort wards opened in our hospital in March 2020 and ended 28 days afterward. The number of patients and blood components transfused in the COVID-19 wards was tabulated. Transfusion rates of each blood component were compared in COVID-19 wards versus all other inpatient wards. RESULTS: COVID-19 wards opened with seven suspected patients and after 4 weeks had 305 cumulative COVID-19 admissions. Forty-one of 305 hospitalized COVID-19 patients (13.4%) received transfusions with 11.1% receiving red blood cells (RBCs), 1.6% platelets (PLTs), 1.0% plasma, and 1.0% cryoprecipitate (cryo). COVID-19 wards had significantly lower transfusion rates compared to non-COVID wards for RBCs (0.03 vs 0.08 units/patient-day), PLTs (0.003 vs 0.033), and plasma (0.002 vs 0.018; all p < 0.0001). Cryo rates were similar (0.008 vs 0.009, p = 0.6). CONCLUSIONS: Hospitalized COVID-19 patients required many fewer blood transfusions than other hospitalized patients. COVID-19 transfusion data will inform planning and preparation of blood resource utilization during the pandemic.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #613578
    Database COVID19

    Kategorien

  5. Article ; Online: Blood transfusion utilization in hospitalized COVID ‐19 patients

    Barriteau, Christina M. / Bochey, Patricia / Lindholm, Paul F. / Hartman, Karyn / Sumugod, Ricardo / Ramsey, Glenn

    Transfusion ; ISSN 0041-1132 1537-2995

    2020  

    Keywords Immunology ; Immunology and Allergy ; Hematology ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    DOI 10.1111/trf.15947
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top